Enovis Corporation

31.51
0.03 (0.10%)
At close: Apr 16, 2025, 11:14 AM

Enovis Revenue Breakdown

Period Ending Apr 1, 2022 Dec 31, 2021 Oct 1, 2021 Jul 2, 2021 Apr 2, 2021 Dec 31, 2020 Oct 2, 2020 Jul 3, 2020 Apr 3, 2020 Dec 31, 2019 Mar 29, 2019 Dec 31, 2018 Sep 28, 2018 Jun 29, 2018 Mar 30, 2018 Dec 31, 2017 Sep 29, 2017 Mar 29, 2013
Fabrication Technology Revenue 647.91M 624.22M 605.97M 629.8M 568.13M 518.67M 491.5M 414.37M 525.54M 333.69M 560.38M n/a n/a n/a 260K 500.23M 482.2M 522.04M
Fabrication Technology Revenue Growth +3.80% +3.01% -3.78% +10.86% +9.54% +5.53% +18.61% -21.15% +57.49% -40.45% n/a n/a n/a -100.00% -99.95% +3.74% -7.63% n/a
Medical Technology Revenue 375.46M 399.06M 359.92M 356.12M 311.08M 309.45M 314.43M 205.99M 290.82M n/a 123.53M n/a n/a n/a n/a n/a n/a n/a
Medical Technology Revenue Growth -5.91% +10.87% +1.07% +14.48% +0.53% -1.58% +52.64% -29.17% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a

Revenue by Geography

Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013 Dec 31, 2012
Foreign Revenue 554.84M 500.34M 2.29B 1.79B 1.86B 2.79B 2.52B 2.65B 2.84B 3.53B 3.37B 3.12B
Foreign Revenue Growth +10.89% -78.15% +28.16% -4.09% -33.19% +10.76% -5.05% -6.70% -19.41% +4.63% +7.87% n/a
United States Revenue 1.15B 1.06B 1.56B 1.28B 1.46B 877.95M 782.2M 995.19M 1.12B 1.1B 836.64M n/a
United States Revenue Growth +8.43% -32.05% +21.84% -12.33% +66.77% +12.24% -21.40% -11.53% +2.46% +31.22% n/a n/a

Operating Expense Breakdown

Period Ending Sep 27, 2024 Jun 28, 2024 Mar 29, 2024 Dec 31, 2023 Sep 29, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jul 1, 2022 Apr 1, 2022 Dec 31, 2021 Oct 1, 2021 Jul 2, 2021 Apr 2, 2021 Dec 31, 2020 Oct 2, 2020 Jul 3, 2020 Apr 3, 2020 Dec 31, 2019 Sep 27, 2019 Jun 28, 2019 Mar 29, 2019 Dec 31, 2018 Sep 28, 2018 Jun 29, 2018 Mar 30, 2018 Dec 31, 2017 Sep 29, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jul 1, 2016 Apr 1, 2016 Dec 31, 2015 Sep 25, 2015 Jun 26, 2015 Mar 27, 2015
Selling, General, and Administrative Revenue 249.85M 241.41M 255.69M 211.01M 204.25M 207.88M 207.16M 208.59M 182.19M 225.48M 369.39M 351.67M 334.42M 337.56M 305.72M 281.42M 278.06M 235.73M 291.3M 285.86M 290.5M 307.94M 318.14M 218.07M 194.83M 204.78M 200.52M 198.79M 181.84M 208.22M 206.05M 197.8M 199.5M 213.55M 214.39M 232.84M 237.25M 222.63M 213.23M
Selling, General, and Administrative Revenue Growth +3.50% -5.59% +21.17% +3.31% -1.75% +0.35% -0.68% +14.49% -19.20% -38.96% +5.04% +5.16% -0.93% +10.41% +8.64% +1.21% +17.96% -19.08% +1.90% -1.60% -5.66% -3.21% +45.89% +11.93% -4.86% +2.13% +0.87% +9.32% -12.67% +1.06% +4.17% -0.85% -6.58% -0.39% -7.93% -1.86% +6.57% +4.41% n/a
Research and Development Revenue 20.49M 23.48M 23.38M 18.32M 19.9M 18.92M 18.19M 14.72M 15.6M 15.66M 14.84M 27.4M 20.2M 21.3M 19.9M 19.2M 16.8M 14.1M 18.5M 17M 16.3M n/a n/a 34.2M n/a n/a n/a n/a n/a n/a n/a 39.3M n/a n/a n/a 41.5M n/a n/a n/a
Research and Development Revenue Growth -12.73% +0.44% +27.61% -7.95% +5.20% +3.99% +23.55% -5.60% -0.40% +5.52% -45.83% +35.64% -5.16% +7.04% +3.65% +14.29% +19.15% -23.78% +8.82% +4.29% n/a n/a -100.00% n/a n/a n/a n/a n/a n/a n/a -100.00% n/a n/a n/a -100.00% n/a n/a n/a n/a